glp 1 phentermine vs GLP-1s: Lower-Cost Weight Loss Options Hot Prescriber Trend: GLP-1 Utilizers

These cases collectively suggest a potential link between semaglutide use and the development or exacerbation of depressive symptoms, warranting closer monitoring in clinical practice

Research in animal models and population studies suggests GLP-1 receptor agonists may reduce dementia risk and improve cognitive function, but clinical trials are still ongoing

In addition to the different study populations and study design in these trials, one potential reason for this heterogeneity in cardiovascular benefit is the structural differences among the GLP-1RAs used in these trials

Pre-diagnosis observational and prescription history associated with Alzheimers disease incidence

/The effect of GLP-1R agonists is not mentioned

T.PessoaT